Mediwound Ltd (MDWD)

[midastouch017]

Mediwound (MDWD) Gets a Buy Rating from H.C. Wainwright

March 18 2022 - 06:17AM

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Mediwound (MDWD – Research Report) today and set a price target of $6.50.
The company's shares closed last Thursday at $1.91, close to its 52-week low of $1.77. According to TipRanks.com, Ramakanth is a 4-star analyst with an average return of 10.5% and a 40.2% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Corvus Pharmaceuticals, Corcept Therapeutics, and Bicycle Therapeutics. Mediwound has an analyst consensus of Strong Buy, with a price target consensus of $5.83, a 211.8% upside from current levels.

https://www.tipranks.com/news/blurbs/mediwound-mdwd-gets-a-buy-rating-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral